We are live on ! Find out more
DADC

D.A. Davidson & Co Portfolio holdings

AUM $18.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+1.38%
1 Year Est. Return
+24.63%
3 Year Est. Return
+70.71%
5 Year Est. Return
+77.77%
10 Year Est. Return
+255.18%
AUM
$5.58B
AUM Growth
+$213M
Cap. Flow
+$154M
Cap. Flow %
2.75%
Top 10 Hldgs %
31.11%
Holding
1,046
New
57
Increased
519
Reduced
312
Closed
44

Sector Composition

Rank Sector Weight
1 Technology 8.44%
2 Financials 7.07%
3 Industrials 6.3%
4 Healthcare 6.02%
5 Consumer Staples 4.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATAXZ
926
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
$196K ﹤0.01%
23,998
+409
+2% +$3.34K
SONO icon
927
Sonos
SONO
$1.75B
$191K ﹤0.01%
+14,250
New +$178K
TECK icon
928
Teck Resources
TECK
$29.5B
$191K ﹤0.01%
11,761
+1,060
+10% +$20K
DSM
929
BNY Mellon Strategic Municipal Bond Fund
DSM
$292M
$190K ﹤0.01%
+22,620
New +$188K
GGN
930
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$767M
$183K ﹤0.01%
42,103
+150
+0.4% +$674
PDX
931
PIMCO Dynamic Income Strategy Fund
PDX
$957M
$175K ﹤0.01%
+10,000
New +$188K
HPE icon
932
Hewlett Packard
HPE
$63.2B
$174K ﹤0.01%
11,443
-2,197
-16% -$31.2K
RDHL
933
Redhill Biopharma
RDHL
$3.85M
$174K ﹤0.01%
25
-1
-4% -$7.28K
NUV icon
934
Nuveen Municipal Value Fund
NUV
$1.91B
$170K ﹤0.01%
16,147
-788
-5% -$8.16K
AMCR icon
935
Amcor
AMCR
$20.6B
$157K ﹤0.01%
3,222
NAD icon
936
Nuveen Quality Municipal Income Fund
NAD
$2.71B
$156K ﹤0.01%
10,868
ZAGG
937
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$154K ﹤0.01%
24,504
-2,000
-8% -$12.9K
NAGE
938
Niagen Bioscience
NAGE
$256M
$138K ﹤0.01%
35,000
FRTA
939
DELISTED
Forterra, Inc
FRTA
$137K ﹤0.01%
19,000
VFF icon
940
Village Farms International
VFF
$235M
$134K ﹤0.01%
14,850
+3,800
+34% +$42.3K
FLG
941
Flagstar Bank National Association
FLG
$5.77B
$134K ﹤0.01%
3,548
VMO icon
942
Invesco Municipal Opportunity Trust
VMO
$647M
$133K ﹤0.01%
10,629
BOCH
943
DELISTED
Bank of Commerce Holdings (CA)
BOCH
$133K ﹤0.01%
12,196
+57
+0.5% +$597
SPRO icon
944
Spero Therapeutics
SPRO
$68.9M
$127K ﹤0.01%
12,000
+2,000
+20% +$21.1K
TEI
945
Templeton Emerging Markets Income Fund
TEI
$310M
$126K ﹤0.01%
13,923
-2,484
-15% -$24.1K
KMF
946
DELISTED
Kayne Anderson NextGen Energy & Infrastructure, Inc.
KMF
$120K ﹤0.01%
11,113
-7,693
-41% -$85K
VTGN icon
947
VistaGen Therapeutics
VTGN
$9.29M
$112K ﹤0.01%
3,500
+750
+27% +$16.7K
VKTX icon
948
Viking Therapeutics
VKTX
$4.04B
$111K ﹤0.01%
16,150
-150
-0.9% -$1.11K
JRO
949
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
$108K ﹤0.01%
11,300
TLPH icon
950
Talphera
TLPH
$70.1M
$103K ﹤0.01%
2,350

Similar funds

D.A. Davidson & Co's Q3 2019 Portfolio in Review

As of Q3 2019, D.A. Davidson & Co held 1,046 positions worth $5.58B, up 4% from $5.37B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

D.A. Davidson & Co's Q3 2019 filing shows 57 new, 519 increased, 312 reduced and 44 closed positions. Its largest new stake was Legg Mason ETF Investment Trust ClearBridge All Cap Growth ESG ETF: 180,780 shares worth $5.72M. The largest sale was Vanguard FTSE Developed Markets ETF, an estimated $130M.

By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.2% a quarter earlier, followed by Financials and Industrials.

  • D.A. Davidson & Co's largest Q3 2019 buy was Legg Mason ETF Investment Trust ClearBridge All Cap Growth ESG ETF: 180,780 shares worth $5.72M.
  • D.A. Davidson & Co added most to iShares Core MSCI Total International Stock ETF in Q3 2019, an estimated $141M increase.
  • D.A. Davidson & Co's biggest Q3 2019 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $130M.
  • D.A. Davidson & Co fully exited Xtrackers MSCI Europe Hedged Equity ETF in Q3 2019, selling an estimated $4.95M.
  • D.A. Davidson & Co's ten largest holdings make up 31% of its $5.58B portfolio in Q3 2019.
  • D.A. Davidson & Co opened 57 new positions and closed 44 in Q3 2019.
  • D.A. Davidson & Co's portfolio value rose 4% quarter-over-quarter to $5.58B.

Based on D.A. Davidson & Co's 13F filing for Q3 2019, filed 5 Nov 2019.